Wegovy vs Mounjaro: Complete Switching Guide & Comparison
Can I Switch to Wegovy from Mounjaro: Key Mechanism Differences
When considering whether you can switch to Wegovy from Mounjaro, understanding their different mechanisms is essential. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone to reduce appetite and promote satiety after smaller meals. Mounjaro contains tirzepatide, which works as a dual GIP and GLP-1 receptor agonist, targeting two separate hormone pathways involved in blood sugar regulation and appetite control.
The switching decision often depends on individual response patterns and tolerability profiles. Some patients find they respond differently to the single-pathway approach of Wegovy compared to Mounjaro's dual-action mechanism. Your prescriber can evaluate whether switching to Wegovy from Mounjaro aligns with your treatment goals, considering factors like current dose tolerance, weight management progress, and any side effects experienced. Both treatments require dose escalation protocols and must be used alongside a reduced-calorie diet and increased physical activity.
Switching to Wegovy from Mounjaro: Pricing and Value Comparison
The cost consideration when switching to Wegovy from Mounjaro varies significantly across the dose escalation schedule. Wegovy starts at £79.99 for the 0.25mg starter dose, progresses through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), reaching £209.99 for the 2.4mg maintenance dose. Our Getting Started bundles provide convenient dose progression—the Intro Duo (0.25mg & 0.5mg) costs £169.99, while the Progress Trio covers three escalation steps for £299.99 with discount codes applied at checkout.
Mounjaro follows a different pricing structure with its own six-dose escalation protocol from 2.5mg to 15mg maximum. When evaluating whether to switch to Wegovy from Mounjaro, consider that Wegovy's 2.4mg maintenance dose represents the final escalation step, whereas Mounjaro continues dose increases up to 15mg. Both treatments are available through our GPhC-registered pharmacy with the same rigorous clinical assessment process, next-day cold-chain delivery, and ongoing prescriber support throughout your weight management journey.
Clinical Evidence: Can I Switch to Wegovy from Mounjaro Safely
Clinical evidence supports supervised switching between different weight management treatments under appropriate medical guidance. The STEP trials demonstrated that patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks in the landmark study by Wilding et al., published in NEJM, 2021. These trials established semaglutide's efficacy profile specifically for chronic weight management in adults with obesity.
When considering switching to Wegovy from Mounjaro, your prescriber will evaluate both treatments' clinical profiles alongside your individual response history. The decision typically involves a washout period and careful monitoring during transition to ensure optimal safety and efficacy. Both medicines are prescription-only treatments requiring ongoing clinical supervision, and switching should only occur under qualified medical guidance with proper assessment of your current treatment response and any contraindications.
How Wegovy Works When Switching from Mounjaro
Wegovy functions as a GLP-1 receptor agonist, mimicking the action of glucagon-like peptide-1, a hormone naturally produced in your intestines after eating. When you inject Wegovy once weekly, it binds to GLP-1 receptors in your brain's appetite centres, reducing hunger signals and increasing feelings of fullness after consuming smaller portions. This mechanism may help reduce food cravings and promote more controlled eating patterns throughout the week. The once-weekly FlexTouch pen delivery system maintains consistent therapeutic levels, supporting appetite regulation between doses. Unlike Mounjaro's dual-pathway approach, Wegovy's focused GLP-1 action provides a more targeted mechanism that some patients prefer when switching treatments under medical supervision.
Switching to Wegovy from Mounjaro: Complete Ordering Process
Switching to Wegovy from Mounjaro through EverydayMeds begins with our comprehensive 3-minute online clinical assessment, specifically designed to evaluate treatment transitions and individual suitability factors. Our qualified prescribers review your assessment within 3 working days (express 24-hour service available), considering your previous Mounjaro experience, current health status, and treatment goals. Once approved, Wegovy ships via next-day delivery using temperature-controlled cold-chain logistics to maintain medication integrity. New customers use discount code FIRST40 at checkout, while returning patients apply DOSE25 to reach our published pricing. Our clinical team provides ongoing support throughout the switching process, ensuring smooth transition protocols and addressing any questions about dose timing or administration differences between treatments.
Storage Advantages When Switching to Wegovy from Mounjaro
A notable practical advantage when switching to Wegovy from Mounjaro involves storage flexibility, particularly important for patients who travel frequently or prefer storage convenience. Wegovy pens maintain potency for up to 6 weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both treatments require initial refrigerated storage at 2–8°C before first use, but Wegovy's extended room temperature tolerance provides greater flexibility for travel, work schedules, or lifestyle considerations. The FlexTouch pen system used for Wegovy offers intuitive dose selection and injection mechanisms, with clear dose escalation from 0.25mg through 2.4mg maintenance dosing. Understanding these practical differences helps patients make informed decisions when considering switching between these prescription-only weight management treatments.
Dose Transition Protocols: Can I Switch to Wegovy from Mounjaro
Switching to Wegovy from Mounjaro requires careful attention to dose transition protocols, as both treatments use different escalation schedules and maximum dosing levels. Wegovy follows a five-step dose escalation over 16 weeks, reaching the 2.4mg maintenance dose, while Mounjaro can escalate through six doses up to 15mg maximum. Your prescriber will determine appropriate starting dose when switching to Wegovy from Mounjaro, potentially beginning with the 0.25mg starter dose or entering at a higher level based on your previous treatment tolerance. The transition typically involves a brief washout period to prevent overlapping effects between treatments.
Both medicines are administered once weekly, but switching requires understanding that semaglutide (Wegovy) and tirzepatide (Mounjaro) have different half-lives and clearance rates from your system. Your prescriber may recommend specific timing protocols and monitoring schedules during the transition period. This careful approach ensures optimal safety when switching to Wegovy from Mounjaro while maintaining therapeutic effectiveness for continued weight management support alongside your reduced-calorie diet and exercise programme.
Order Your Wegovy Prescription: Switching Made Simple
Ready to explore switching to Wegovy from Mounjaro? Start with our clinical assessment at everydaymeds.co.uk/collections/weight-loss, where our prescribers can evaluate your treatment history and switching suitability. New customers use discount code FIRST40 for optimal pricing, while returning patients apply DOSE25 at checkout. Our GPhC #9012878 registered pharmacy ensures full regulatory compliance and clinical safety throughout your switching journey. Both Wegovy and Mounjaro remain available through our service, giving you treatment flexibility under qualified medical supervision. Take the first step towards evaluating your weight management options with our comprehensive clinical assessment today.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
